• Aurélien Lambert, Julia Salleron, Alexandre Harlé, James J Biagi, Agnès Leroux, Jacques Thomas, Laure Monard, Jérôme Cros, Frédéric Marchal, Ahmet Ayav, and Thierry Conroy.
• Department of Medical Oncology, Institut de Cancérologie de Lorraine and INSERM, UMR 1319 INSPIIRE, Université de Lorraine, Vandœuvre-lès-Nancy, France.
• Ann. Surg. 2024 Jul 23.

ObjectiveThis study investigated the correlation between positive resection margins and outcomes in patients with pancreatic ductal adenocarcinoma who underwent surgery and adjuvant chemotherapy according to the pivotal trial PRODIGE 24-CCTG PA-6.BackgroundThe primary focus is on elucidating the prognostic significance of specific resection margins, including those associated with the superior-mesenteric vein (SMV), medial, and posterior pancreas.MethodsThe analysis involved 400 patients across multiple centers in France and Canada. Surgical resection and subsequent adjuvant chemotherapy were core interventions. This study assessed the prognostic impact of resection margins, highlighting the significance of standardized pathology assessments. Additionally, the influence of chemotherapy regimen choice, comparing gemcitabine to mFOLFIRINOX, on the implications of positive resection margins was examined.ResultsOnly three margins, SMV (HR=1.48 95% CI [1.11;1.96], P<.001), medial (HR=1.92 95% CI [1.36;2.73], P<.001) and posterior (HR=1.65 95% CI [1.21;2.24], P=.002), had a significant prognostic impact on disease-free survival and were sufficient compared with the seven recommended margins (Kappa=0.90 95% CI [0.87; 0.94]). R1 status was significant independent prognostic factor for poorer survival in gemcitabine-treasted patients (HR=1.97 95% CI [1.23;3.16], P=.005) but lost its significance with mFOLFIRINOX (HR=1.46 95% CI [0.91;2.35], P=.114).ConclusionsAll efforts should be made to evaluate the three margins of the highest prognostic value, with the others being secondary. A key finding of this study is the likely effect of mFOLFIRINOX on local invasion in operated patients, which seems to correct the impairment related to margin involvement, probably explaining the improvements in DFS and OS.Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.

20 keywords...

hide…